Patents by Inventor James L. Hartley

James L. Hartley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7455974
    Abstract: The invention relates to a nucleic acid marker ladder which is a restriction endonuclease digest, wherein a nucleic acid restriction endonuclease digest is a collection of nucleic acid fragments resulting from complete digestion of one or more nucleic acids by one or more restriction endonucleases; the restriction endonuclease digest contains at least 3 fragments; and the size of the fragments in base pairs is a multiple of an integer, wherein the integer is 10 or more.
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: November 25, 2008
    Assignee: Invitrogen Corporation
    Inventor: James L. Hartley
  • Publication number: 20080241889
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.
    Type: Application
    Filed: December 18, 2006
    Publication date: October 2, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Jonathan D. Chesnut, John Carrino, Louis Leong, Knut Madden, Martin A.G. Gleeson, James Fan, Michael A. Brasch, David Cheo, James L. Hartley, Devon R.N. Byrd, Gray F. Temple
  • Publication number: 20080214408
    Abstract: The invention provides a microarray and methods for producing a protein microarray. The array comprises multiple nucleic acid molecules immobilized on a substrate, each comprising (i) a protein-binding domain and (ii) a nucleic acid sequence encoding a fusion protein comprising a polypeptide of interest and a DNA-binding protein that binds the protein-binding domain, and one or more fusion proteins produced from the multiple nucleic acid molecules. Each fusion protein is immobilized on the substrate via binding to a nucleic acid sequence comprising the protein-binding domain present on the nucleic acid molecule from which the fusion protein is produced or on the substrate. The invention also provides a method of analyzing protein interactions with, for example, other proteins, lipids and drugs.
    Type: Application
    Filed: April 18, 2008
    Publication date: September 4, 2008
    Applicant: GOVERNMENT OF THE UINTED STATES OF AMERICA, REPRESENTED BY THE SECRETARY DEPT.
    Inventors: Deb K. Chatterjee, Kalavathy Sitaraman, James L. Hartley, Cassio Baptista, David J. Munroe
  • Patent number: 7408049
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: August 5, 2008
    Assignee: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Patent number: 7393632
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites with unique specificity. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different. Such molecules and/or compounds or combinations of such molecules and/or compounds can also be bound through recombination to various structures or supports according to the invention.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: July 1, 2008
    Assignee: Invitrogen Corp.
    Inventors: David Cheo, Michael A. Brasch, Gary F. Temple, James L. Hartley, Devon R. N. Byrd
  • Patent number: 7351578
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites with unique specificity. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different. Such molecules and/or compounds or combinations of such molecules and/or compounds can also be bound through recombination to various structures or supports according to the invention.
    Type: Grant
    Filed: August 14, 2003
    Date of Patent: April 1, 2008
    Assignee: Invitrogen Corp.
    Inventors: David Cheo, Michael A. Brasch, Gary F. Temple, James L. Hartley, Devon R. N. Byrd
  • Patent number: 7304130
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: November 2, 1999
    Date of Patent: December 4, 2007
    Assignee: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch
  • Patent number: 7282326
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: January 30, 2002
    Date of Patent: October 16, 2007
    Assignee: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch
  • Patent number: 7244560
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: July 17, 2007
    Assignee: Invitrogen Corporation
    Inventors: Jonathan D. Chestnut, John Carrino, Louis Leong, Knut Madden, Martin Gleeson, James Fan, Michael A. Brasch, David Cheo, James L. Hartley, Devon R.N. Byrd, Gary F. Temple
  • Patent number: 7223576
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: March 10, 2004
    Date of Patent: May 29, 2007
    Assignee: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch
  • Patent number: 7198924
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.
    Type: Grant
    Filed: March 4, 2004
    Date of Patent: April 3, 2007
    Assignee: Invitrogen Corporation
    Inventors: Jonathan D. Chesnut, John Carrino, Louis Leong, Knut Madden, Martin A. G. Gleeson, James Fan, Michael A. Brasch, David Cheo, James L. Hartley, Devon R. N. Byrd, Gary F. Temple
  • Patent number: 7132520
    Abstract: The invention relates to a nucleic acid marker ladder which is a restriction endonuclease digest, wherein a nucleic acid restriction endonuclease digest is a collection of nucleic acid fragments resulting from complete digestion of one or more nucleic acids by one or more restriction endonucleases; the restriction endonuclease digest contains at least 3 fragments; and the size of the fragments in base pairs is a multiple of an integer, wherein the integer is 10 or more.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: November 7, 2006
    Assignee: Invitrogen Corporation
    Inventor: James L. Hartley
  • Patent number: 6924098
    Abstract: The present invention provides nucleic acid molecules which may be used as standards for estimating the size (in base pairs) and mass of linear, double-stranded or single-stranded nucleic acid molecules separated by size. The nucleic acid molecules of the invention may be DNA molecules, RNA molecules or DNA/RNA hybrid molecules, and may be double-stranded or single-stranded. The invention also provides methods for producing nucleic acid sizing ladders from these nucleic acid molecules, ladders produced by such methods, and methods for estimating the size and mass of nucleic acid molecules by comparison to these nucleic acid sizing ladders.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: August 2, 2005
    Assignee: Invitrogen Corporation
    Inventors: A-Li W. Hu, James L. Hartley, Heather J. Jordan
  • Publication number: 20040265863
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.
    Type: Application
    Filed: March 4, 2004
    Publication date: December 30, 2004
    Applicant: Invitrogen Corporation
    Inventors: Jonathan D. Chesnut, John Carrino, Louis Leong, Knut Madden, Martin A.G. Gleeson, James Fan, Michael A. Brasch, David Cheo, James L. Hartley, Devon R.N. Byrd, Gary F. Temple
  • Publication number: 20040253631
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: July 19, 2004
    Publication date: December 16, 2004
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20040229229
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites with unique specificity. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different. Such molecules and/or compounds or combinations of such molecules and/or compounds can also be bound through recombination to various structures or supports according to the invention.
    Type: Application
    Filed: August 14, 2003
    Publication date: November 18, 2004
    Applicant: Invitrogen Corporation
    Inventors: David Cheo, Michael A. Brasch, Gary F. Temple, James L. Hartley, Devon R. N. Byrd
  • Publication number: 20040219673
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: March 10, 2004
    Publication date: November 4, 2004
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch
  • Publication number: 20040171157
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: April 8, 2004
    Publication date: September 2, 2004
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20040171156
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: April 2, 2004
    Publication date: September 2, 2004
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Patent number: 6720140
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: February 4, 2000
    Date of Patent: April 13, 2004
    Assignee: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch